---
schema_version: "secwatch.filing_event.v1"
accession: "0001040130-24-000020"
form_type: "8-K"
ticker: "PETS"
cik: "0001040130"
company_name: "PETMED EXPRESS INC"
filed_at: "2024-04-15T23:59:59+00:00"
generated_at: "2026-06-03T22:43:46.929726+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# PetMed Express Q3 net loss $2.0M; completes sales tax restatement

## Summary
- Revenue $65.3M, up 11% YoY, driven by PetCareRx acquisition; legacy sales declined.
- Net loss $(0.10)/diluted share vs $(0.01) loss last year; Adjusted EBITDA $924K vs $2.7M.
- Cash $49.4M, no debt; AutoShip & Save and PetPlus made up 52% of revenue (vs 42% a year ago).
- Restatement completed; sales tax liability now $24.2M from prior $7.8M as of Mar 2023.
- Company now current on all SEC filings; restatement had no impact on FY2024 revenue or cash.

## SEC filing metadata
- accession: 0001040130-24-000020
- form_type: 8-K
- ticker: PETS
- cik: 0001040130
- company_name: PETMED EXPRESS INC
- filed_at: 2024-04-15T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1040130/000104013024000020/0001040130-24-000020-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1040130/000104013024000020/pets-20240415.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001040130-24-000020
- JSON: https://secwatch.observer/filing/0001040130-24-000020.json
- Plain text: https://secwatch.observer/filing/0001040130-24-000020.txt

## Key facts
- Earnings Releases
  PETMED EXPRESS INC reported fiscal third quarter 2024 results: revenue Net sales for the quarter ended December 31, 2023, were $65.3 million, net income Net loss for the quarter ended December 31, 2023 was $2.0 million, EPS $(0.10) per diluted share.
  - Period: fiscal third quarter 2024
  - Revenue: Net sales for the quarter ended December 31, 2023, were $65.3 million
  - Net income: Net loss for the quarter ended December 31, 2023 was $2.0 million
  - EPS: $(0.10) per diluted share
  - Result: reported results
  source text: Net sales for the quarter ended December 31, 2023, were $65.3 million, compared to $58.9 million for the third quarter in the prior year, an increase of 11% year over year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1040130/000104013024000020/0001040130-24-000020-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.